Mesenchymal Stem Cells in the Treatment of COVID-19
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241914800 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Bei-Cyuan Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70403, Taiwan. Hauptthemen laut MEDLINE: COVID-19, Mesenchymal Stem Cell Transplantation, Respiratory Distress Syndrome, Mesenchymal Stem Cells. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Since the emergence of the coronavirus disease 2019 (COVID-19) pandemic, many lives have been tragically lost to severe infections. The COVID-19 impact extends beyond the respiratory system, affecting various organs and functions. In severe cases, it can progress to acute respiratory distress syndrome (ARDS) and multi-organ failure, often fueled by an excessive immune response known as a cytokine storm. Mesenchymal stem cells (MSCs) have considerable potential because they can mitigate inflammation, modulate immune responses, and promote tissue regeneration. Accumulating evidence underscores the efficacy and safety of MSCs in treating severe COVID-19 and ARDS. Nonetheless, critical aspects, such as optimal routes of MSC administration, appropriate dosage, treatment intervals, management of extrapulmonary complications, and potential pediatric applications, warrant further exploration. These research avenues hold promise for enriching our understanding and refining the application of MSCs in confronting the multifaceted challenges posed by COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70403, Taiwan.
- Department of Pediatrics, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.
- School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
- Department of Emergency Medicine, Tungs' Taichung Metro Harbor Hospital, Taichung 43503, Taiwan.
- Department of Nursing, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli 35664, Taiwan.
- Department of Pediatrics, Taichung Veterans General Hospital, Taichung 43503, Taiwan.
ORCID-Profile: Bei-Cyuan Guo, Kang-Hsi Wu, Yu-Jun Chang, Mao-Jen Lin
Zitieren
APA
Guo, B. C., Wu, K. H., Chen, C. Y., Lin, W. Y., Chang, Y. J., Lee, T. A., Lin, M. J., & Wu, H. P. (2023). Mesenchymal Stem Cells in the Treatment of COVID-19. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914800
Vancouver
Guo BC, Wu KH, Chen CY, Lin WY, Chang YJ, Lee TA, et al. Mesenchymal Stem Cells in the Treatment of COVID-19. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914800
BibTeX
@article{Guo2023,
author = {Guo, Bei-Cyuan and Wu, Kang-Hsi and Chen, Chun-Yu and Lin, Wen-Ya and Chang, Yu-Jun and Lee, Tai-An and Lin, Mao-Jen and Wu, Han-Ping},
title = {Mesenchymal Stem Cells in the Treatment of COVID-19},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241914800}
}
EUVIMED